Inventor · disambiguated record
Daniel L. Alkon
Also filed as: ALKON DANIEL · ALKON DANIEL L · ALKON MD DANIEL L
58 granted patents·68 pending applications·811 citations·filing 1983–2024
99Inventor score
Files withBRNI NEUROSCIENCES INST22ALKON DANIEL L14SYNAPTOGENIX INC12COGNITIVE RES ENTERPRISES INC10BLANCHETTE ROCKEFELLER NEUROSCIENCES INST8
Top patents by PatentIndex Score
126 records- 0193US7803400B2Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrierBRNI NEUROSCIENCES INST·Filed 2007·Granted Sep 28, 2010·14 cites·44 claims
- 0292US7977377B2Treatment of depressive disordersBRNI NEUROSCIENCES INST·Filed 2007·Granted Jul 12, 2011·14 cites·5 claims
- 0392US7595167B2Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratioBRNI NEUROSCIENCES INST·Filed 2005·Granted Sep 29, 2009·25 cites·41 claims
- 0491US10323011B2PKC-activating compounds for the treatment of neurodegenerative diseasesCOGNITIVE RES ENTERPRISES INC·Filed 2015·Granted Jun 18, 2019·3 cites·3 claims
- 0591US7682627B2Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrierBRNI NEUROSCIENCES INST·Filed 2007·Granted Mar 23, 2010·16 cites·36 claims
- 0690US9119825B2PKC-activating compounds for the treatment of neurodegenerative diseasesNELSON THOMAS J·Filed 2012·Granted Sep 1, 2015·4 cites·3 claims
- 0790US6825229B2Methods for Alzheimer's Disease treatment and cognitive enhancementBRNI NEUROSCIENCES INST·Filed 2002·Granted Nov 30, 2004·31 cites·6 claims
- 0889US8163800B2PKC-activating compounds for the treatment of neurodegenerative diseasesNELSON THOMAS J·Filed 2009·Granted Apr 24, 2012·7 cites·15 claims
- 0988US8658134B2Fibroblast growth patterns for diagnosis of Alzheimer's diseaseCHIRILA FLORIN VALENTIN·Filed 2010·Granted Feb 25, 2014·13 cites·30 claims
- 1088US6552053B2Controlling attention and memory by altering neuronal carbonic anhydrase activityUS HEALTH·Filed 2001·Granted Apr 22, 2003·24 cites·26 claims
- 1188US6107050ADiagnostic test for alzheimers diseaseUS HEALTH·Filed 1998·Granted Aug 22, 2000·114 cites·11 claims
- 1287US11826345B2Dosing regimens of PKC activatorsCOGNITIVE RES ENTERPRISES INC·Filed 2020·Granted Nov 28, 2023·1 cites·7 claims
- 1387US11045447B2Methods for inducing synaptogenesis with synaptic growth factor activating compoundsNEUROTROPE BIOSCIENCE INC·Filed 2020·Granted Jun 29, 2021·2 cites·18 claims
- 1487US10696644B2PKC-activating compounds for the treatment of neurodegenerative diseasesCOGNITIVE RES ENTERPRISES INC·Filed 2019·Granted Jun 30, 2020·1 cites·8 claims
- 1583US11173140B2Dosing regimens of PKC activatorsCOGNITIVE RES ENTERPRISES INC·Filed 2019·Granted Nov 16, 2021·2 cites·13 claims
- 1683US9163032B2Esters of DCPLA and methods of treatment using the sameBRNI NEUROSCIENCES INST·Filed 2012·Granted Oct 20, 2015·6 cites·21 claims
- 1783US9066923B2Methods for Alzheimer's disease treatment and cognitive enhancementALKON DANIEL·Filed 2009·Granted Jun 30, 2015·5 cites·13 claims
- 1883US6080582ACell tests for Alzheimer's diseaseUS HEALTH·Filed 1998·Granted Jun 27, 2000·45 cites·7 claims
- 1983US2024025870A1Pkc-activating compounds for the treatment of neurodegenerative diseasesSYNAPTOGENIX INC·Filed 2023·Application pending·0 cites
- 2081US8703812B2Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learningALKON DANIEL L·Filed 2012·Granted Apr 22, 2014·3 cites·7 claims
- 2181US7220833B2Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrierNELSON THOMAS·Filed 2003·Granted May 22, 2007·12 cites·33 claims
- 2281US5822742ADynamically stable associative learning neural network systemUS ARMY·Filed 1993·Granted Oct 13, 1998·114 cites·51 claims
- 2380US11820745B2PKC-activating compounds for the treatment of neurodegenerative diseasesSYNAPTOGENIX INC·Filed 2022·Granted Nov 21, 2023·0 cites·6 claims
- 2479US9539235B2Methods for Alzheimer's disease treatment and cognitive enhancementBLANCHETTE ROCKEFELLER NEUROSCIENCES INST·Filed 2013·Granted Jan 10, 2017·3 cites·2 claims
- 2578US9188595B2Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylationZHAO WEI-QIN·Filed 2010·Granted Nov 17, 2015·5 cites·16 claims
- 2678US7576055B2Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrierBRNI NEUROSCIENCES INST·Filed 2007·Granted Aug 18, 2009·2 cites·15 claims
- 2777US12016837B2Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseasesSYNAPTOGENIX INC·Filed 2022·Granted Jun 25, 2024·0 cites·3 claims
- 2877US11390596B2PKC-activating compounds for the treatment of neurodegenerative diseasesCOGNITIVE RES ENTERPRISES INC·Filed 2020·Granted Jul 19, 2022·0 cites·6 claims
- 2976US5222195ADynamically stable associative learning neural system with one fixed weightUSA·Filed 1992·Granted Jun 22, 1993·37 cites·3 claims
- 3075US9797913B2Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)BLANCHETTE ROCKEFELLER NEUROSCIENCES INST·Filed 2013·Granted Oct 24, 2017·2 cites·7 claims
- 3175US7682807B2Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylationBRNI NEUROSCIENCES INST·Filed 2002·Granted Mar 23, 2010·6 cites·62 claims
- 3275US5580748ADiagnostic tests for alzheimers diseaseUS HEALTH·Filed 1993·Granted Dec 3, 1996·37 cites·24 claims
- 3375US5119469ANeural network with weight adjustment based on prior history of input signalsUSA·Filed 1989·Granted Jun 2, 1992·33 cites·7 claims
- 3474US9597312B2Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activatorsSUN MIAO-KUN·Filed 2011·Granted Mar 21, 2017·4 cites·8 claims
- 3574US2024390324A1Methods of treating and preventing neurodegenerative diseases with hgf activating compoundsSYNAPTOGENIX INC·Filed 2024·Application pending·0 cites
- 3674US2025064776A1Treatment of amyotrophic lateral sclerosis using pkc activatorsSYNAPTOGENIX INC·Filed 2024·Application pending·0 cites
- 3773US7514402B2Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrierNELSON THOMAS·Filed 2007·Granted Apr 7, 2009·1 cites·18 claims
- 3873US6821979B2Synergistic enhancement of cognitive abilityBRNI NEUROSCIENCES INST·Filed 2002·Granted Nov 23, 2004·5 cites·2 claims
- 3972US9446020B2Methods for Alzheimer'S disease treatment and cognitive enhancementBLANCHETTE ROCKEFELLER NEUROSCIENCES INST·Filed 2015·Granted Sep 20, 2016·1 cites·15 claims
- 4071US9889183B2PKC activators and anticoagulant in regimen for treating strokeBLANCHETTE ROCKEFELLER NEUROSCIENCES INST·Filed 2015·Granted Feb 13, 2018·1 cites·27 claims
- 4171US2018325856A1Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseasesCOGNITIVE RES ENTERPRISES INC·Filed 2018·Application pending·0 cites
- 4270US10137106B2Compositions and methods to treat niemann-pick diseaseBLANCHETTE ROCKEFELLER NEUROSCIENCES INST INC·Filed 2017·Granted Nov 27, 2018·1 cites·20 claims
- 4370US9962357B2Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseasesBLANCHETTE ROCKEFELLER NEUROSCIENCES INST·Filed 2014·Granted May 8, 2018·0 cites·26 claims
- 4470US9107890B2PKC activators and anticoagulant in regimen for treating strokeALKON DANIEL L·Filed 2011·Granted Aug 18, 2015·1 cites·29 claims
- 4570US2023235378A1Lzheimer's disease-specific alterations of protein kinase c epsilon (pkc-epsilon protein levelsWEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV·Filed 2022·Application pending·0 cites
- 4670US2023340600A1Synchronized Cell-Based CompositionsNEUROGX LLC·Filed 2023·Application pending·0 cites
- 4769US5446829AArtificial network for temporal sequence processingUS ARMY·Filed 1993·Granted Aug 29, 1995·36 cites·12 claims
- 4868US12405268B2Lymphocyte-based morphometric test for alzheimer's diseaseNeuroDiagnostics LLC·Filed 2022·Granted Sep 2, 2025·0 cites·14 claims
- 4968US10317396B2Peripheral diagnostic methods for screening Alzheimer's disease using beta amyloid and intercellular communicationCHIRILA FLORIN V·Filed 2012·Granted Jun 11, 2019·2 cites·8 claims
- 5068US6300085B1Diagnostic method for Alzheimer's diseaseUS HEALTH·Filed 1995·Granted Oct 9, 2001·27 cites·13 claims
Showing the top 50 of 126 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel L. Alkon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →